Phase Ii Study Of Gemcitabine And Split-Dose Cisplatin Plus Pembrolizumab As Neoadjuvant Therapy Prior To Radical Cystectomy (Rc) In Patients With Muscle-Invasive Bladder Cancer (Mibc).

Tracy L Rose,Michael Roger Harrison,Allison Mary Deal,Chelsea K. Osterman,Sundhar Ramalingam,Young E. Whang,Blaine Y Brower,Marc Bjurlin,Angela B. Smith,Matthew E. Nielsen,Hung-Jui Tan,Eric M. Wallen,Daniel J. George,Tian Zhang,Anthony Drier,William Y. Kim,Matthew I. Milowsky

JOURNAL OF CLINICAL ONCOLOGY（2021）

Cited 6|Views29

No score

Abstract

396Background: Cisplatin-based neoadjuvant chemotherapy is standard of care in MIBC with improved pathologic response and overall survival (OS) compared to RC alone. Pembrolizumab (pembro) is activ...

Translated text

Key words

Neoadjuvant Therapy

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined